Which Electrolyte should be measured during lithium therapy?

AIIMS Raipur NO - 2017 (Shift-1)

Pharmacology

Easy

Appeared in: AIIMS Raipur NO - 2017 (Shift-1)

Explanation

Lithium is a mood stabilizer with a narrow therapeutic index, where small changes in serum levels can lead to toxicity.
The kidneys are the primary route of lithium excretion, and its handling is closely linked to sodium.
Lithium and sodium are both monovalent cations that compete for reabsorption in the proximal tubules of the kidneys.
When sodium levels are low (hyponatremia), the kidneys increase the reabsorption of sodium to conserve it. This process also causes increased reabsorption of lithium.
Increased lithium reabsorption leads to higher serum lithium levels, significantly increasing the risk of lithium toxicity.
Therefore, monitoring sodium levels is a critical safety measure for any patient undergoing lithium therapy.

Option B: Potassium does not have the direct competitive renal reabsorption relationship with lithium that sodium does.
Option C: Chloride is an anion that often follows sodium to maintain electrical neutrality, but it is the sodium cation level itself that directly influences lithium reabsorption.
Option D: Magnesium levels do not directly regulate the renal clearance of lithium in the way sodium does.

Visual 1: Diagram - An illustration of a kidney nephron's proximal tubule, showing the transport channels where sodium (Na+) and lithium (Li+) compete for reabsorption into the bloodstream. This visual helps clarify the physiological basis for their interaction.
Visual 2: Chart - A chart showing the therapeutic range (0.6-1.2 mEq/L) and toxic levels (>1.5 mEq/L) of lithium, with callouts for early, moderate, and severe toxicity symptoms.

Clinical Relevance

Nursing practice connection: Knowing Pharmacology: Drug-Electrolyte Interaction (Lithium and Sodium) helps nurses interpret findings accurately and avoid errors in routine assessment, medication administration, and patient teaching.
Patient education is a key nursing responsibility. Nurses must teach patients on lithium to maintain a consistent intake of both salt and fluids (2.5-3 L/day) and to avoid starting low-sodium diets without medical consultation.
Nurses must be vigilant in monitoring for early signs of lithium toxicity, which include fine hand tremors, nausea, vomiting, diarrhea, and muscle weakness. These can progress to coarse tremors, confusion, ataxia, and seizures if not addressed.
What if? A patient on lithium reports starting a new 'water pill' (thiazide diuretic) for hypertension and has been feeling unwell. The nurse's priority action would be to suspect potential lithium toxicity due to sodium loss, advise the patient to hold the next lithium dose, and immediately notify the healthcare provider for orders to check serum lithium and sodium levels.

How to Approach the Question

First, identify the core of the question. It asks for a specific electrolyte to monitor with a specific drug, lithium.
Recall the key pharmacological properties of lithium. Remember it's a salt with a narrow therapeutic window and is cleared by the kidneys.
Access knowledge about lithium's interaction with the body. The key interaction is its relationship with another salt in the kidneys.
Compare the options. Lithium is chemically similar to sodium. This similarity causes them to be handled similarly by the kidneys.
Conclude that a low level of sodium causes the body to retain lithium, leading to toxicity. Therefore, sodium is the correct answer.
Eliminate the other options by recalling that while potassium, chloride, and magnesium are important, they do not have this direct, competitive relationship with lithium in the kidneys.

Concept Tested & Keywords

Q8_qXX24oeAZyt3264q8Vh